MM are buying CRN in the Emerging Companies Portfolio, allocating 3% around $1.31 - Market Matters

Skip to Content

Home Actions MM are buying CRN in the Emerging Companies Portfolio,…

26/07/2024

MM are buying CRN in the Emerging Companies Portfolio, allocating 3% around $1.31

Subscribe to Market Matters Blog

Latest Reports

Afternoon report 11/05/2026

The Match Out: ASX gets hit early but recovers ground, CSL whacked on 4th downgrade in a year

The ASX started the week on the back foot today on renewed concerns around the Middle East conflict after President Trump rejected Iran's latest peace proposal over the weekend sending oil prices higher again.

Morning report 11/05/2026

Macro Monday: Earnings, not social media posts, ultimately drive stocks

Outside of the post-COVID rebound, corporate America has just delivered one of its strongest earnings seasons in more than a decade. Approximately 85% of S&P 500 companies beat expectations, with the Magnificent Seven posting profit growth well in excess of 50%, providing the engine room for the broader rally.

Blog Categories

image description

Relevant suggested news and content from the site

Back to top